Assignee
MAPP BIOPHARMACEUTICAL INC
US·8 granted patents·5 pending applications·7 citations·filing 2012–2024
Top patents by PatentIndex Score
13 records- 0184US11725045B2Anti-respiratory syncytial virus antibodies, methods of their generation and useMAPP BIOPHARMACEUTICAL INC·Filed 2018·Granted Aug 15, 2023·2 cites·45 claims
- 0284US11407817B2Monoclonal antibodies and cocktails for treatment of Ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2020·Granted Aug 9, 2022·1 cites·18 claims
- 0384US11407816B2Monoclonal antibodies and cocktails for treatment of Ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2020·Granted Aug 9, 2022·1 cites·18 claims
- 0484US11254732B2Monoclonal antibodies and cocktails for treatment of Ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2020·Granted Feb 22, 2022·1 cites·9 claims
- 0584US11242379B2Monoclonal antibodies and cocktails for treatment of Ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2020·Granted Feb 8, 2022·1 cites·9 claims
- 0684US11242378B2Monoclonal antibodies and cocktails for treatment of Ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2020·Granted Feb 8, 2022·1 cites·9 claims
- 0781US12209117B2Monoclonal antibodies and cocktails for treatment of Ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2022·Granted Jan 28, 2025·0 cites·18 claims
- 0873US2024228597A1Anti-respiratory syncytial virus antibodies, methods of their generation and useMAPP BIOPHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 0969US2025206808A1Antibodies Against HenipavirusesMAPP BIOPHARMACEUTICAL INC·Filed 2024·Application pending·0 cites
- 1066US10836810B2Monoclonal antibodies and cocktails for treatment of ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2018·Granted Nov 17, 2020·0 cites·9 claims
- 1154US2019263894A1Monoclonal antibody cocktails for treatment of ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2019·Application pending·0 cites
- 1252US2019247501A1Monoclonal antibody cocktails for treatment of ebola infectionsMAPP BIOPHARMACEUTICAL INC·Filed 2019·Application pending·0 cites
- 1342US2013149300A1MONOCLONAL ANTIBODIES WITH ALTERED AFFINITIES FOR HUMAN FCyRI, FCyRIIIa, AND C1q PROTEINSMAPP BIOPHARMACEUTICAL INC·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MAPP BIOPHARMACEUTICAL INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →